Differential antibody responses to a distinct region of human papillomavirus minor capsid proteins

Monica E. Embers, Lynn R. Budgeon, Timothy D. Culp, Cynthia A. Reed, Martin D. Pickel, Neil D. Christensen

Research output: Contribution to journalArticlepeer-review

19 Scopus citations


A peptide derived from the human papillomavirus type 16 (HPV-16) minor capsid protein, L2, has previously been reported to induce cross-neutralizing antibodies in mice. In this report, four HPV L2 peptides, including the HPV-16 peptide and its HPV type 6 and 11 homologues, along with extended peptides containing a conserved set of amino acids, were used to immunize rabbits and mice. Antibody responses were evaluated for specificity and ability to neutralize viral infection in vitro with a quantitative reverse transcriptase (RT)-polymerase chain reaction (PCR) assay. All peptide immunizations resulted in cognate and cross-peptide reactivity, but this did not translate equally into recognition of full-length protein, VLP, or neutralization of virus in vitro. This report provides the first evidence of cross-neutralization of authentic HPV by antiserum to L2 peptides. Comparison of the anti-peptide serum reactivity, especially with regard to neutralization of virus, indicates that the extended peptides may offer more potential to induce adequate responses for cross-protective immunity.

Original languageEnglish (US)
Pages (from-to)670-680
Number of pages11
Issue number5-6
StatePublished - Jan 26 2004

All Science Journal Classification (ASJC) codes

  • Molecular Medicine
  • General Immunology and Microbiology
  • General Veterinary
  • Public Health, Environmental and Occupational Health
  • Infectious Diseases


Dive into the research topics of 'Differential antibody responses to a distinct region of human papillomavirus minor capsid proteins'. Together they form a unique fingerprint.

Cite this